Search

everythinglearnresearchcommunity

for

Search:↓

Use "female pattern hair loss" term, finasteride may help, more research needed.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Hair length and thickness are related, with thickness peaking at about a quarter of the hair's maximum length.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Women with androgenetic alopecia may have higher blood pressure levels.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Gene variation affects prostate issues and hair loss.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

New oral treatment, finasteride, effectively and safely treats common hair loss.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.